Literature DB >> 8491524

Pneumocystis carinii pneumonia in heart transplant recipients.

P Grossi1, G B Ippoliti, C Goggi, P Cremaschi, M Scaglia, L Minoli.   

Abstract

Seven cases of Pneumocystis carinii pneumonia (PCP) (two in 1988, three in 1989, one in 1990 and one in 1991) have been observed in a group of 241 heart transplant recipients transplanted in Pavia, Italy, from November 1985 through December 1991. Median time to onset of symptoms was 100 days after transplantation (range 59-333 days). Diagnosis was achieved in all patients by cytological examination of bronchoalveolar lavage (BAL) fluid and/or transbronchial biopsy. Clinical and roentgenographic features were remarkably similar in all PCP-affected heart transplant recipients. A dry, persistent hacking cough associated with dyspnoea was consistently observed. Fever ranged from 37.6 to 39.4 degrees C, median leukocyte count and median arterial oxygen saturation (SaO2) values were 7,300/mm3 (range 3,000-16,000/mm3) and 61% (range 49.3-93%), respectively. Median CD4+ count at the onset of symptoms was 211/mm3 (range 28-739/mm3). The only patient experiencing a recurrence of PCP had a CD4+ cell count of 28/mm3 at the end of treatment with trimethoprim-sulfamethoxazole (TMP-SMX). In all patients human cytomegalovirus was isolated from BAL fluids; however, treatment with TMP-SMX alone (20 mg/kg/day of TMP) was consistently followed by a complete recovery.

Entities:  

Mesh:

Year:  1993        PMID: 8491524     DOI: 10.1007/BF01710735

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

1.  Rapid microscopy technique for detection of Pneumocystis carinii in fresh clinical specimens.

Authors:  G Chichino; A Bruno; C Cevini; S Gatti; M Scaglia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-08       Impact factor: 3.267

2.  Possible prevention of Pneumocystis carinii pneumonia by pentamidine aerosol after bone marrow transplantation.

Authors:  F X Mahon; A Sadoun; E Benz-Lemoine; F Roblot-Casenave; F Guilhot; J Tanzer
Journal:  Bone Marrow Transplant       Date:  1991-07       Impact factor: 5.483

Review 3.  Infection as a complication of heart transplantation.

Authors:  J Linder
Journal:  J Heart Transplant       Date:  1988 Sep-Oct

4.  Increasing incidence of Pneumocystis carinii pneumonia in renal transplant patients.

Authors:  T Talseth; H Holdaas; D Albrechtsen; K J Berg; P Fauchald; A Naalsund; K P Nordal; A G Skar; G Sødal; A Flatmark
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

5.  Pneumocystis carinii pneumonia: a cluster of eleven cases.

Authors:  C Singer; D Armstrong; P P Rosen; D Schottenfeld
Journal:  Ann Intern Med       Date:  1975-06       Impact factor: 25.391

6.  Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins.

Authors:  G Gerna; M G Revello; E Percivalle; M Zavattoni; M Parea; M Battaglia
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

7.  Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia.

Authors:  G Gerna; D Zipeto; M Parea; M G Revello; E Silini; E Percivalle; M Zavattoni; P Grossi; G Milanesi
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

8.  Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids.

Authors:  J M Hofflin; I Potasman; J C Baldwin; P E Oyer; E B Stinson; J S Remington
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

9.  Infections in heart transplant recipients: the experience of the Italian heart transplantation program. Italian Study Group on Infections in Heart Transplantation.

Authors:  P Grossi; R De Maria; A Caroli; M S Zaina; L Minoli
Journal:  J Heart Lung Transplant       Date:  1992 Sep-Oct       Impact factor: 10.247

10.  Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia.

Authors:  G Gerna; M G Revello; E Percivalle; F Morini
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

View more
  4 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

2.  Pneumocystis carinii pneumonia in HIV-negative patients with haematologic disease.

Authors:  J van der Lelie; D Venema; E J Kuijper; R P van Steenwijk; M H van Oers; L L Thomas; A E von dem Borne
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

3.  Outcomes of Pneumocystis jiroveci pneumonia infections in pediatric heart transplant recipients.

Authors:  Benton Ng; Anne Dipchand; David Naftel; Paolo Rusconi; Gerard Boyle; Theo Zaoutis; R Erik Edens
Journal:  Pediatr Transplant       Date:  2011-12

Review 4.  Pentamidine in Pneumocystis jirovecii prophylaxis in heart transplant recipients.

Authors:  Adem Ilkay Diken; Ozlem Erçen Diken; Onur Hanedan; Seyhan Yılmaz; Ata Niyazi Ecevit; Emir Erol; Adnan Yalçınkaya
Journal:  World J Transplant       Date:  2016-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.